Q BioMed Inc. (QBIO) is a publicly traded company in the Unknown sector. Across all available filings, 4 corporate insiders have executed 66 transactions totaling $795.4K, demonstrating a bearish sentiment with -$795.4K in net insider flow. The most recent transaction on May 26, 2022 involved a transaction of 200,000 shares valued at $4.0B.
No significant insider buying has been recorded for QBIO in the recent period.
No significant insider selling has been recorded for QBIO in the recent period.
Based on recent SEC filings, insider sentiment for QBIO is bearish with an Insider Alignment Score of 0/100 and a net flow of -$795.4K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Q BioMed Inc. (QBIO) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 4 insiders are actively trading QBIO stock, having executed 66 transactions in the past 90 days. The most active insider is Denis Corin (Executive), who has made 15 transactions totaling $4.0B.
Get notified when executives and directors at QBIO file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| May 26, 2022 | Corin Denis | Executive | Award | 200,000 | $20000.00 | $4.0B | Large |
| Feb 1, 2021 | S. Rosenstadt William | Executive | Award | 35,000 | $N/A | $0 | |
| Oct 16, 2019 | S. Rosenstadt William | Executive | Award | 115,761 | $N/A | $0 | |
| Oct 9, 2019 | Panicucci Rick | Executive | Award | 500 | $N/A | $0 | |
| Aug 28, 2019 | Panicucci Rick | Executive | Award | 2,000 | $N/A | $0 | |
| May 31, 2019 | Panicucci Rick | Executive | Award | 500 | $N/A | $0 | |
| Apr 9, 2019 | Panicucci Rick | Executive | Award | 1,500 | $N/A | $0 | |
| Jan 4, 2019 | Panicucci Rick | Executive | Award | 1,000 | $N/A | $0 | |
| Nov 16, 2018 | Panicucci Rick | Executive | Award | 2,500 | $N/A | $0 | |
| Jul 12, 2018 | Corin Denis | Executive | Sale | 6,400 | $2.11 | $13.5K | |
| Jul 12, 2018 | Panicucci Rick | Executive | Award | 1,500 | $N/A | $0 | |
| Jul 10, 2018 | Corin Denis | Executive | Sale | 7,000 | $2.85 | $19.9K | |
| Jul 9, 2018 | Corin Denis | Executive | Sale | 7,000 | $3.37 | $23.6K | |
| Jul 6, 2018 | Corin Denis | Executive | Sale | 6,900 | $3.58 | $24.7K | |
| Jul 5, 2018 | Corin Denis | Executive | Sale | 6,600 | $3.54 | $23.4K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Award(A) | 11 | $4.0B | 100.0% |
Sale(S) | 54 | $795.4K | 0.0% |
Gift(G) | 1 | $0 | 0.0% |
Insider selling pressure at Q BioMed Inc. has increased, with 4 insiders executing 66 transactions across all time. Total sales of $795.4K significantly outpace purchases of $0, resulting in a net outflow of $795.4K. This selling activity appears largely discretionary, which may warrant closer attention from investors.